Outcome prediction of the new 2022 European LeukemiaNet (ELN) risk classification by genetics for adult acute myeloid leukemia (AML) patients (pts): An Alliance study
- Citation:
- Blood vol 140 (suppl 1) 6318–20
- Meeting Instance:
- ASH 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3914
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Krzysztof Mrózek Jessica Kohlschmidt James S. Blachly Deedra Nicolet Andrew J. Carroll Kellie J. Archer Alice S. Mims Karilyn T. Larkin Shelley Orwick Christopher C. Oakes Jonathan E. Kolitz Bayard L. Powell William G. Blum Guido Marcucci Maria R. Baer Geoffrey Uy Wendy Stock John C. Byrd Ann-Kathrin Eisfeld
- Networks:
- CA043, LAPS-AL002, LAPS-IL057, LAPS-MO011, LAPS-OH007, MD015, NC002, NORTHWELL, OH070
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-20202, CALGB-8461, CALGB-9665
- Phases:
- N/A
- Keywords: